Researchers are seeking to address the psychological impact of patients who have survived VTE.
What is the best current strategy for addressing patients with COVID-19 who are at high risk for thrombosis but are not in the ICU?
Researchers assessed outcomes and risk factors associated with thromboembolic events among patients with COVID-19 pneumonia.
Medulloblastoma survivors had an increased risk of long-term adverse outcomes.
Researchers sought to compare the efficacy of momelotinib with danazol in patients with thrombocytopenic myelofibrosis who were symptomatic and anemic.
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
Researchers sought to determine whether catheter-directed thrombolysis would be effective in patients with postpartum iliofemoral deep venous thrombosis.
Researchers sought to determine whether rilzabrutinib would be effective in treating immune thrombocytopenia.
The phase 3 ADVANCE trial evaluated the efficacy and safety of efgartigimod in 131 adults with primary ITP.
Researchers sought to assess any recent changes in racial inequities trends in stroke treatment and in-hospital mortality, and whether racial inequities differed among patients living in rural areas.
Researchers sought to determine whether thromboprophylaxis would reduce venous thromboembolism risk in patients with SCD and a central venous access device.
Researchers sought to determine whether patients with thrombotic antiphospholipid syndrome may be at greater risk of stroke when treated with apixaban instead of warfarin.
Researchers sought to determine whether adding prednisone to sirolimus would improve outcomes in patients with Kasabach-Merritt phenomenon of kaposiform hemangioendothelioma.
Is there a relationship between OSA and cognitive impairment in patients with minor ischemic stroke?
In a prospective, longitudinal study, researchers determined the rates and factors associated with recurrent ischemic stroke, death, and new-onset atrial fibrillation among young adults.
The AHA and the ASA released a joint scientific statement on the use of endovascular therapy or thrombolysis in adult patients with preexisting dementia or disability.
Researchers investigated whether thrombophilia in patients with IBD significantly contributes to developing venous thromboembolic events.
Researchers sought to determine the risk factors for both venous and arterial thrombosis in neonates admitted to neonatal intensive care units.
Two studies show increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1-S
Researchers sought to determine the state of detection and initiation of prophylactic treatment for patients with hTTP.
A recent study sought to refine international risk classification guidelines on preventing VTE after discontinuation of anticoagulation therapy.
Investigators compared outcomes of thrombolytic therapy and surgery as first-line treatment for patients with obstructive prosthetic valve thrombosis.
Researchers sought to determine the cost-effectiveness of eltrombopag for patients with immune thrombocytopenia compared with intravenous immunoglobulin.
Researchers sought to determine the underlying reasons for thrombosis risk in patients with severe COVID-19.
A study sought to determine whether overweight/obesity is a factor in the development of thrombosis in cancer patients with peripherally inserted central catheters.
Researchers sought to determine whether interferon-alpha or hydroxyurea would be effective treatments for patients with essential thrombocythemia and polycythemia vera.
Findings from a retrospective study identified risk factors for thrombosis in patients with post-polycythemia vera myelofibrosis, compared with patients with polycythemia vera.
Researchers sought to determine whether there is a link between COVID-19 and endothelial damage and hypercoagulability.
Exercise benefits extend beyond liver-related outcomes, independent of weight loss or dietary change
Researchers sought to evaluate the safety and functional outcomes of intravenous alteplase among patients who took NOACs prior to stroke and compare the outcomes of patients who did not take long-term anticoagulants.
Researchers sought to determine whether there is an association between INR and anticoagulation-related outcomes in an Asian population after AVR or MVR.
Factors associated with poor functional outcomes included age older than 60 years, diabetes mellitus, increased NIHSS, LVO
The objective of the study was to assess the association between psoriatic arthritis and venous thromboembolism events.
More intensive LDL-C-lowering with statin-based therapies linked to reduced risk for recurrent stroke for patients with evidence of atherosclerosis
How does methylprednisolone dose and duration affect rates of VTE and mortality among patients with COVID-19 pneumonia?
Direct oral anticoagulants reduce recurrent VTE events by 41 percent, with no significant increase in major bleeding, compared to dalteparin
About 1.7 years of more intensive hypertensive treatment required to prevent one stroke per 200 adults aged 65 years or older
Researchers sought to determine whether HITT would be associated with a high re‐exploration rate of vascularized lymph node transplantations in primary lymphedema.
The updated CHEST guideline on antithrombotic therapy for VTE includes 4 new PICO questions as well as updated recommendations based on newer evidence.
Rate of symptomatic intracranial hemorrhage lower with tenecteplase than the current standard medication for thrombolysis, alteplase
Researchers sought to develop a prognostic model for patients with transplant-associated thrombotic microangiopathy after allo-HCT.
Almost all hospitalized COVID-19 patients with a bleeding event were receiving mechanical ventilation, full-dose anticoagulation
Researchers sought to develop a model to estimate the risk of DVT in patients treated for liver failure using an artificial liver support system.
Researchers sought to describe a case of vaccine-induced immune thrombotic thrombocytopenia in a patient after an adenovirus vector-based COVID-19 vaccine.
Researchers sought to determine incidence of VTE and bleeding events for patients with CAT who switched to rivaroxaban treatment after at least 4 weeks of standard anticoagulation therapy.
Researchers sought to determine the pathology behind possible vaccine-induced immune thrombocytopenia and thrombosis following COVID-19 vaccinations.
Researchers sought to determine how the plasma level of complement C5 is related to the risk of developing VTE.
Researchers sought to determine the rate of misdiagnoses for acute cerebral venous thrombosis cases by imaging in an emergency setting.
Researchers sought to determine the incidence of bleeding and thrombotic events in patients receiving CAR-T therapy.
In a large-scale analysis, researchers determined whether endovascular mechanical thrombectomy is a safe and effective therapy for acute ischemic stroke during pregnancy and the postpartum period.
A new study suggests apixaban may be a potential treatment for cancer-associated venous thromboembolism, with possible variation in outcomes by cancer site.